Combining programmed intracavernous PGE1 injections and sildenafil on demand to salvage sildenafil nonresponders
- 10 February 2005
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in International Journal of Impotence Research
- Vol. 17 (4), 354-358
- https://doi.org/10.1038/sj.ijir.3901290
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Erectile dysfunction: management updateCMAJ : Canadian Medical Association Journal, 2004
- Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapyInternational Journal of Impotence Research, 2003
- Viability and Safety of Combination Drug Therapies for Erectile DysfunctionJournal of Urology, 2003
- Ureteral EndometriosisJournal of Urology, 2003
- Acceptance, efficacy and preference of Sildenafil in patients on long term auto-intracavernosal therapy: a study with follow-up at one yearInternational Journal of Impotence Research, 2002
- Rationale for combination therapy of intraurethral prostaglandin E1 and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapyInternational Journal of Impotence Research, 2002
- SILDENAFIL VERSUS INTRACAVERNOUS INJECTION THERAPY: EFFICACY AND PREFERENCE IN PATIENTS ON INTRACAVERNOUS INJECTION FOR MORE THAN 1 YEARJournal of Urology, 2000
- EFFICACY, SAFETY AND PATIENT ACCEPTANCE OF SILDENAFIL CITRATE AS TREATMENT FOR ERECTILE DYSFUNCTIONJournal of Urology, 2000
- Current perspectives on intracavernosal pharmacotherapy for erectile dysfunctionInternational Journal of Impotence Research, 2000
- Intracavernosal self-injection therapy in men with erectile dysfunction: Satisfaction and attrition in 119 patientsInternational Journal of Impotence Research, 1999